Logo

Usnoflast well tolerated, shows signs of efficacy in ALS patients - ALS News Today

Last Updated: 25.06.2025 09:21

Usnoflast well tolerated, shows signs of efficacy in ALS patients - ALS News Today

An experimental oral treatment from Zydus Lifesciences was well tolerated at all tested doses and showed signs of slowing disease progression in people with amyotrophic lateral sclerosis (ALS).

That… [+4080 chars]